BIOMAT Database Logo BIOMAT Database Logo

Future of oral iron chelator deferiprone (L1) 1993

F Pfannkuch, and P Bentley, and H P Schnebli

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077543 Deferiprone A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA. 1,2-Dimethyl-3-hydroxy-4-pyridinone,1,2-Dimethyl-3-hydroxypyrid-4-one,1,2-Dimethyl-3-hydroxypyridin-4-one,3-Hydroxy-1,2-dimethyl-4-pyridinone,DMOHPO,Ferriprox,HDMPP,1,2 Dimethyl 3 hydroxy 4 pyridinone,1,2 Dimethyl 3 hydroxypyrid 4 one,1,2 Dimethyl 3 hydroxypyridin 4 one,3 Hydroxy 1,2 dimethyl 4 pyridinone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

F Pfannkuch, and P Bentley, and H P Schnebli
Future of oral iron chelator deferiprone (L1)
June 1993, Lancet (London, England),
F Pfannkuch, and P Bentley, and H P Schnebli
Future of oral iron chelator deferiprone. (L1) ICOC committee.
June 1993, Lancet (London, England),
F Pfannkuch, and P Bentley, and H P Schnebli
Pharmaceutical analysis of the oral iron chelator deferiprone (DMHP,L1).
August 1996, Pharmacy world & science : PWS,
F Pfannkuch, and P Bentley, and H P Schnebli
Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload.
February 1995, British journal of haematology,
F Pfannkuch, and P Bentley, and H P Schnebli
The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1).
December 2000, Transfusion science,
F Pfannkuch, and P Bentley, and H P Schnebli
Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
November 1997, The Journal of surgical research,
F Pfannkuch, and P Bentley, and H P Schnebli
[Treatment of iron overload states with oral administration of the chelator agent, L1 (Deferiprone)].
September 1994, Vnitrni lekarstvi,
F Pfannkuch, and P Bentley, and H P Schnebli
Toxicity of oral iron chelator L1.
June 1993, The Journal of the Association of Physicians of India,
F Pfannkuch, and P Bentley, and H P Schnebli
Development of oral iron chelator L1.
April 1993, Lancet (London, England),
F Pfannkuch, and P Bentley, and H P Schnebli
Toxicity of oral iron chelator L1.
April 1993, Lancet (London, England),
Copied contents to your clipboard!